AMSTERDAM · EST. 2026
Onpeps
PEPTIDE DECISION INTELLIGENCE
Subscribe
← PEPTIDE LIBRARY
SLEEPGRADE CMOSTLY PRECLINICAL

DSIP

Delta sleep-inducing peptide; sleep architecture

A nonapeptide first isolated from rabbit cerebral venous blood during induced sleep. Named for its proposed effect on slow-wave sleep, though findings across studies have been inconsistent.

ALSO KNOWN AS Delta sleep-inducing peptide
REGULATORY STATUS · RESEARCH COMPOUND

Research compound — not approved for human use. Compounds in this category have not been approved for human use; availability is typically restricted to laboratory research.

§ EVIDENCE BASE
462
PUBLICATIONS
indexed in PubMed
1
REGISTERED TRIALS
listing it as an intervention
0
PHASE 2–4 TRIALS
reached later-stage testing
MECHANISMDelta sleep-inducing peptide; sleep architecture
CATEGORYSleep
EVIDENCE GRADEC — Mostly preclinical
STATUSResearch compound — not approved for human use
TYPICAL RECONSTITUTION5 mg vial + 2 mL BAC water
ROUTESubcutaneous — abdomen
COUNTS RETRIEVED2026-07-23 · re-run the PubMed query
§ DOCUMENTED DOSING
Standard100–200 mcg before bed
Frequencynightly or as needed
Cycleshort cycles; assess tolerance

Ranges compiled from published protocols, not a clinical guideline. Convert a dose into syringe units with the dosage calculator.

NOT MEDICAL ADVICE

This page summarises how much a compound has been studied. A high publication count is not evidence that something works, is safe, or is legal to obtain where you live. Consult a qualified healthcare provider before acting on anything here.

THE WEEKLY BRIEF

Peptide intelligence, every Monday.

One concise email: the newest research, evidence updates, and quality signals — no hype, no spam.

Onpeps

Our mission is to make peptide research clear, credible, and usable for people who refuse to rely on hype.

EXPLORE
FOLLOW
PEPTIDE INFORMATION YOU CAN VERIFY© 2026 ONPEPS · AMSTERDAM, NETHERLANDS · NOT MEDICAL ADVICE